Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:4.2.2.7 (
heparinase
)
1,270
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
BETA2
/
NeuroD
protein is important for regulating insulin gene transcription and for the terminal differentiation of islet cells, including insulin- and glucagon-producing cells. We reported that
BETA2
/
NeuroD
protein can permeate several cell types, including pancreatic islets, because of an arginine- and lysine-rich protein transduction domain (PTD) sequence in its structure. Here we provide genetic and biochemical evidence that cell membrane heparan sulfate proteoglycans are involved in extracellular
BETA2
/
NeuroD
internalization. We tested whether soluble glycosaminoglycans (GAGs) could inhibit
BETA2
/
NeuroD
internalization. Heparin almost completely prevented
BETA2
/
NeuroD
entry, whereas chondroitin sulfate A, B, and C caused only limited inhibition. Moreover, treatment with
heparinase
III impaired
BETA2
/
NeuroD
internalization, whereas treatment with chondroitinase ABC, or with chondroitinase AC, was completely ineffective in inhibiting
BETA2
/
NeuroD
internalization. We also examined various mutant cell lines originating from CHOK1 cells and defective in GAG biosynthesis. The observation using mutant cell lines supports the notion that the selective sulfation of heparan sulfate is an important determinant for
NeuroD
/heparan sulfate recognition. These data indicate that cell surface heparan sulfate proteoglycans are required for
BETA2
/
NeuroD
internalization and that
BETA2
/
NeuroD
protein transduction could be a safe and valuable strategy for enhancing insulin gene transcription without requiring gene transfer technology.
...
PMID:BETA2/NeuroD protein transduction requires cell surface heparan sulfate proteoglycans. 1714 99